Clinical Trials Browser

Clonal Cytopenia of Undetermined Significance × Clear all

NCT05102370 2026-01-27

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Phase 1 Completed

Classical hematology

Clonal Cytopenia of Undetermined Significance

NCT05641831 2026-01-02

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

Phase 2 Recruiting

Classical hematology

Clonal Cytopenia of Undetermined Significance